Stocks · Health care · Pharmaceutical Preparations

Braveheart Bio, Inc.

BRVE
United States Fiscal year ends December CIK 0002131524
$20.02 +4.87% Close, 9 Oct 2026
Price $20.02 −30.75% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 6 Aug 2026. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Financial statements

Nothing filed here yet

No statements have been read for BRVE. They arrive with the nightly refresh; a company joins the screen the first time one is.